Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: A safety, feasibility, and efficacy study from the Hoosier oncology group
Shadia Jalal, Pablo Bedano, Lawrence Einhorn, Sumeet Bhatia, Rafat Ansari, Naftali Bechar, Karuna Koneru, Ramaswamy Govindan, Jingwei Wu, Menggang Yu, Bryan Schneider, Nasser Hanna
Dive into the research topics of 'Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: A safety, feasibility, and efficacy study from the Hoosier oncology group'. Together they form a unique fingerprint.